296 related articles for article (PubMed ID: 16150124)
1. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease.
Walkley SU; Thrall MA; Haskins ME; Mitchell TW; Wenger DA; Brown DE; Dial S; Seim H
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):536-44. PubMed ID: 16150124
[TBL] [Abstract][Full Text] [Related]
2. Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.
McGlynn R; Dobrenis K; Walkley SU
J Comp Neurol; 2004 Dec; 480(4):415-26. PubMed ID: 15558784
[TBL] [Abstract][Full Text] [Related]
3. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.
Brooks DA; Gibson GJ; Karageorgos L; Hein LK; Robertson EF; Hopwood JJ
Mol Genet Metab; 2005 Jul; 85(3):236-8. PubMed ID: 15979036
[TBL] [Abstract][Full Text] [Related]
4. Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI.
Auclair D; Hopwood JJ; Lemontt JF; Chen L; Byers S
Mol Genet Metab; 2007 Aug; 91(4):352-61. PubMed ID: 17544310
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic rescue after adeno-associated virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI.
Ho TT; Maguire AM; Aguirre GD; Surace EM; Anand V; Zeng Y; Salvetti A; Hopwood JJ; Haskins ME; Bennett J
J Gene Med; 2002; 4(6):613-21. PubMed ID: 12439853
[TBL] [Abstract][Full Text] [Related]
6. Feline mucopolysaccharidosis type VI: correction of glycosaminoglycan storage in myoblasts by retrovirus-mediated transfer of the feline N-acetylgalactosamine 4-sulfatase gene.
Yogalingam G; Bielicki J; Hopwood JJ; Anson DS
DNA Cell Biol; 1997 Oct; 16(10):1189-94. PubMed ID: 9364929
[TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation.
Simonaro CM; Haskins ME; Abkowitz JL; Brooks DA; Hopwood JJ; Zhang J; Schuchman EH
Gene Ther; 1999 Jan; 6(1):107-13. PubMed ID: 10341882
[TBL] [Abstract][Full Text] [Related]
8. Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.
Litjens T; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):282-95. PubMed ID: 11668612
[TBL] [Abstract][Full Text] [Related]
9. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
[TBL] [Abstract][Full Text] [Related]
10. Abnormal granulation of blood granulocytes in mucopolysaccharidosis VI-a case report.
Krishnagiri C; Ajanahalli RR; Kashyap S; Anegundi R; Boranaik L
Ann Diagn Pathol; 2013 Feb; 17(1):137-9. PubMed ID: 22056033
[TBL] [Abstract][Full Text] [Related]
11. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF
Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126
[TBL] [Abstract][Full Text] [Related]
12. Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry.
Crawley A; Ramsay SL; Byers S; Hopwood J; Meikle PJ
Pediatr Res; 2004 Apr; 55(4):585-91. PubMed ID: 14711884
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal corneal transplantation fails to correct mucopolysaccharidosis VI corneal storage.
Aguirre G; Raber I; Yanoff M; Haskins M
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2702-13. PubMed ID: 1639616
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.
Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA
Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients.
Lin WD; Lin SP; Wang CH; Hwu WL; Chuang CK; Lin SJ; Tsai Y; Chen CP; Tsai FJ
Clin Chim Acta; 2008 Aug; 394(1-2):89-93. PubMed ID: 18486607
[TBL] [Abstract][Full Text] [Related]
16. Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI.
Byers S; Nuttall JD; Crawley AC; Hopwood JJ; Smith K; Fazzalari NL
Bone; 1997 Nov; 21(5):425-31. PubMed ID: 9356736
[TBL] [Abstract][Full Text] [Related]
17. [Type VI-A mucopolysaccharidosis (Maroteaux-Lamy disease). Clinico-pathologic case report].
Stürmer J
Klin Monbl Augenheilkd; 1989 Apr; 194(4):273-81. PubMed ID: 2498570
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.
Crawley AC; Brooks DA; Muller VJ; Petersen BA; Isaac EL; Bielicki J; King BM; Boulter CD; Moore AJ; Fazzalari NL; Anson DS; Byers S; Hopwood JJ
J Clin Invest; 1996 Apr; 97(8):1864-73. PubMed ID: 8621770
[TBL] [Abstract][Full Text] [Related]
19. Craniofacial abnormalities in animal models of mucopolysaccharidoses I, VI, and VII.
Sheridan O; Wortman J; Harvey C; Hayden J; Haskins M
J Craniofac Genet Dev Biol; 1994; 14(1):7-15. PubMed ID: 8006122
[TBL] [Abstract][Full Text] [Related]
20. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
